Natural vaginal progesterone is associated with minimal psychological side effects: A preliminary study

Journal of Women’s Health and Gender-Based Medicine

Volumn 10, Issue 10, 2001, Pages 991-997

  Shantha, Shanmugan ^a   Brooks Gunn, Jeanne ^b   Locke, Rebecca J ^a   Warren, Michelle P ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADERM TTS 50; ESTRADIOL; PROGESTERONE;

ADULT; AFFECTIVE NEUROSIS; AMENORRHEA; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; FEMALE; GEL; HORMONE SUBSTITUTION; HUMAN; IRRITABILITY; MULTICENTER STUDY; OBSESSION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOMATIZATION;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; AMENORRHEA; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; GELS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHALAMIC DISEASES; MIDDLE AGED; NEW YORK CITY; OVARIAN FAILURE, PREMATURE; PROGESTERONE; TREATMENT OUTCOME;

EID: 0035686526     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460901317193567     Document Type: Article

References (27)

1. Treatment of postmenopausal osteoporosis
2. Hormone replacement therapy and prevention of nonvertebral fractures: A meta-analysis of randomized trials
3. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
4. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen
5. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
6. Progestogen addition during estrogen replacement therapy-Effects on vasomotor symptoms and mood
7. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progesterone postmenopausal replacement therapy
8. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women
9. The effects of norethisterone in postmenopausal women on estrogen replacement therapy: A model for the premenstral syndrome
10. Progesterone intolerance and complaints with hormone replacement therapy in menopausal women
11. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen
12. Vaginal progesterone in menopause: Crinone 4% in cyclical and constant combined regimens
13. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites
14. Targeted drug delivery in gynecology: The first uterine pass effect
15. A new clinical option for hormone replacement therapy in women with secondary amenorrhea: Effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial and withdrawal bleeding
16. Osteopenia in exercise-induced amenorrhea using ballet dancers as a model: A longitudinal study
17. Comfort, effectiveness and self-awareness as criteria of improvement in psychotherapy
18. The Hopkins Symptom Checklist: Assessing emotional distress in obstetric-gynecologic practice
19. Hypothalamic amenorrhea and hidden nutritional insults
20. Physician/patient agreement on symptoms as a predictor of retention in outpatient care
21. Stress fractures in female athletea
22. Psychological status of previously infertile couples after a successful pregnancy
23. Symptom relief and side effects of postmenopausal hormones: Results from the Postmenopausal Estrogen/Progestin Intervention Trial
24. No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: Double-blind, placebo-controlled, crossover trial
25. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy
26. Progestogens used in menopause: Side effects, mood and quality of life
27. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone